|
|
|
42
|
7151AM
|
CASODEX 150MG TAB (AZN) BICALUTAMID
|
BICALUTAMIDE
|
CASODEX
|
28'S
|
C
|
654.87
|
23.39
|
TAB
|
0
|
BLIS
|
AZN
|
ASTRAZENECA AB
|
COL
|
AVENTA BARBADOS
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
7151AN
|
CASODEX 50MG CAP (AZN/COL) BICALUTAMIDE
|
BICALUTAMIDE
|
CASODEX
|
28'S
|
C
|
226.30
|
8.08
|
CAPSULE
|
0
|
CAP
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
7151AN
|
CASODEX 50MG CAP (AZN) BICALUTAMIDE (C)
|
BICALUTAMIDE
|
CASODEX
|
28'S
|
C
|
226.3
|
8.0822
|
CAP
|
0
|
BOX
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
7151AN
|
CASODEX 50MG CAP (AZN) BICALUTAMIDE
|
BICALUTAMIDE
|
CASODEX
|
28'S
|
C
|
226.30
|
8.08
|
CAP
|
0
|
BLIS
|
AZN
|
ASTRAZENECA AB
|
COL
|
AVENTA BARBADOS
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
7151AW
|
AAP-FLUTAMIDE 250MG TAB (APO/COL) FLUTAMIDE
|
FLUTAMIDE
|
AAP-FLUTAMIDE
|
100'S
|
A
|
32.76
|
0.33
|
TABLET
|
180
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
7151P
|
APO-BICALUTAMIDE 50MG TAB (APO/COL)
|
BICALUTAMIDE
|
APO-BICALUTAMIDE
|
30'S
|
C
|
17.67
|
0.59
|
TABLET
|
0
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
7151R
|
BICALUTAMIDE 150MG TAB (CIP/AHI)
|
BICALUTAMIDE
|
BICALUTAMIDE
|
30'S
|
C
|
93.24
|
3.11
|
TABLET
|
0
|
TAB
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
7151S
|
BICALUTAMIDE 50MG TAB (CIP) (C)
|
BICALUTAMIDE
|
BICALUTAMIDE
|
30'S
|
C
|
17.67
|
0.589
|
TAB
|
0
|
BOX
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
72017
|
METALYSE 50MG INJ (BOE/STO) TENECTEPLASE
|
TENECTEPLASE
|
METALYSE
|
50MG VIAL
|
BQ
|
2,535.76
|
2,535.76
|
INJECTION
|
0
|
VIAL
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
201220
|
THROMBOLYTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
72017
|
METALYSE 50MG INJ (BOE) TENECTEPLASE (BQ)
|
TENECTEPLASE
|
METALYSE
|
50MG VIAL
|
BQ
|
2873
|
2872.9966
|
VIAL
|
0
|
VIAL
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
201220
|
THROMBOLYTIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
THROMBOLYTIC AGENTS
|
|
|
|
|
42
|
72017
|
METALYSE 50MG INJ (BOE) TENECTEPLASE
|
TENECTEPLASE
|
METALYSE
|
50MG VIAL
|
BQ
|
2,873.00
|
2,873.00
|
VIAL
|
0
|
VIAL
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
201220
|
THROMBOLYTIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
THROMBOLYTIC AGENTS
|
|
|
|
|
42
|
7201N
|
ELAXIM 50MG INJ (EMC) TENECTEPLASE
|
TENECTEPLASE
|
ELAXIM
|
50MG VIAL
|
BQ
|
1,902.83
|
1,902.83
|
VIAL
|
0
|
VIAL
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
201220
|
THROMBOLYTIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
THROMBOLYTIC AGENTS
|
|
|
|
|
40
|
72211
|
BETAFERON 8MU/ML INJ (BSP/AHI) INTERFERON BET
|
INTERFERON BETA 1B
|
BETAFERON
|
15X3ML
|
C
|
2,786.28
|
2,786.28
|
INJECTION
|
0
|
VIAL
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081820
|
INTERFERONS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
42
|
72211
|
BETAFERON 8MU/ML INJ (BSP) INTERFERON B1
|
INTERFERON BETA 1B
|
BETAFERON
|
15X3ML
|
BQ
|
2,721.04
|
2,721.04
|
VIAL
|
0
|
VIAL
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081820
|
INTERFERONS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
INTERFERONS
|
|
|
|
|
40
|
72212
|
AVONEX 30MCG/ML INJ (BGN/PHA) INTERFERON BETA 1A
|
INTERFERON BETA 1A
|
AVONEX
|
4X30MCG
|
C
|
2,560.66
|
2,560.66
|
INJECTION
|
0
|
VIAL
|
BGN
|
BIOGEN
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081820
|
INTERFERONS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
72212
|
AVONEX 30MCG/ML INJ (BGN) INTERFERON BETA 1A (BQ)
|
INTERFERON BETA 1A
|
AVONEX
|
4X30MCG
|
BQ
|
2611.87
|
2611.8744
|
VIAL
|
0
|
VIAL
|
BGN
|
BIOGEN
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081820
|
INTERFERONS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
INTERFERONS
|
|
|
|
|
40
|
72218
|
BETAFERON 8MU/ML INJ (BSP/COL) INTERFERON BET
|
INTERFERON BETA 1B
|
BETAFERON
|
15X3ML
|
C
|
2,786.28
|
2,786.28
|
INJECTION
|
0
|
VIAL
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081820
|
INTERFERONS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
72218
|
BETAFERON 8MU/ML INJ (BSP) INTERFERON B1 (C)
|
INTERFERON BETA 1B
|
BETAFERON
|
15X3ML
|
C
|
2786.28
|
2786.2821
|
VIAL
|
0
|
VIAL
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081820
|
INTERFERONS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
INTERFERONS
|
|
|
|
|
42
|
72218
|
BETAFERON 8MU/ML INJ (BSP) INTERFERON B1
|
INTERFERON BETA 1B
|
BETAFERON
|
15X3ML
|
BQ
|
2,476.15
|
2,476.15
|
VIAL
|
0
|
VIAL
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
AVENTA BARBADOS
|
|
081820
|
INTERFERONS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
INTERFERONS
|
|
|
|
|
40
|
72416
|
MANGANESE 0.1 MG/ML INJ (KWA/ATB)
|
MANGANESE
|
MANGANESE
|
10ML
|
BQ
|
25.04
|
25.04
|
INJECTION
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
4012
|
REPLACEMENT THERAPY
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
